InvestorsHub Logo
Followers 21
Posts 1385
Boards Moderated 0
Alias Born 06/14/2017

Re: dabullishbear post# 15107

Thursday, 12/28/2017 12:58:28 PM

Thursday, December 28, 2017 12:58:28 PM

Post# of 21373
Nice substantive post. Refreshing!

From these prices, the Phase I results are really all that matter to determine if we'll make some money or not here.

Over the period 2006-2015, 63% of oncology drugs in FDA trials moved from Phase I to Phase II (see page 9).

https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf

Even better, drugs with ODD (like Prolanta) have a Phase I to Phase II approval rate of closer to 75%.

http://www.raredr.com/news/orphan-approval

Based on what we know already about Prolanta, my opinion is the likelihood of Prolanta moving on to Phase II is at least that high.

I won't speculate on PPS if/when we get news of successful Phase I, but I expect, even with additional dilution, that it will be trading substantially north of here. Agree re: huge potential upside.

Good luck to all.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.